Status:
RECRUITING
AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)
Lead Sponsor:
Implenomics
Collaborating Sponsors:
Population Council
RTI International
Conditions:
Cervical Cancer
Kaposi Sarcoma
Eligibility:
All Genders
15-39 years
Phase:
NA
Brief Summary
Adolescents and young adults living with HIV experience higher premature mortality from cancer than their uninfected peers. In Zambia, because of multilevel barriers, interventions for early diagnosis...
Detailed Description
Zambia is a global epicenter for HIV with a large number of adolescents and young adults living with HIV (AYAHIV). Compared with their uninfected peers, AYAHIV are at increased risk of developing canc...
Eligibility Criteria
Inclusion
- 15 to 39 years of age at the time of study enrolment, on antiretroviral medication (ART) for at least 6 months and with no pending plans to move from current residence during the 3-year study duration
Exclusion
- pregnant at study enrolment
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2027
Estimated Enrollment :
4100 Patients enrolled
Trial Details
Trial ID
NCT06004011
Start Date
May 1 2024
End Date
July 31 2027
Last Update
November 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Public Health Facilities
Lusaka, Zambia